Hawkins James B's Form 4 filing
Iradimed Corp (IRMD) · filed Nov 24, 2021
- Accession no.
- 0000898432-21-000740
- Filed
- Nov 24, 2021
- Trade date
- Nov 23-24, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.86M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hawkins James BCIK 0000898243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Common Stock | AGrant or awardAcquired | +6,038 | $1.48F1 | +$8,936.24 | 23,306 | Direct | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −6,038 | $41.20F2 | −$248,765.6 | 17,268 | Direct | |
| Nov 24, 2021 | Common Stock | AGrant or awardAcquired | +37,454 | $1.48F1 | +$55,431.92 | 54,722 | Direct | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −37,454 | $42.95F3 | −$1,608,649.3 | 17,268 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Common Stock | MOption exerciseDisposed | −6,038 | $0.00 | $0 | 83,962 | Direct | |
| Nov 24, 2021 | Common Stock | MOption exerciseDisposed | −37,454 | $0.00 | $0 | 46,508 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
Referenced by the price of 2 transactions in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $41.20 to $41.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $42.25 to $44.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.